NEW YORK, December 30, 2025, 07:16 ET — Premarket
Shares of Exzeo Group, Inc. (XZO) were indicated flat at $23.32 in premarket trading, which takes place before the regular 9:30 a.m. ET open. The stock last traded at $23.16 after hours, down 0.7%.
The newly listed insurance-technology firm has been sensitive to year-end liquidity, when thinner volumes can magnify moves. Exzeo went public on the New York Stock Exchange in November after raising $168 million in an initial public offering, with parent HCI Group retaining a majority stake.
The broader backdrop was cautious. U.S. stock index futures were steady after a tech-led slide on Monday, with investors awaiting minutes from the Federal Reserve’s Dec. 9–10 meeting, Reuters reported. “As we near the year end, investors are facing a dilemma,” said Kathleen Brooks, research director at XTB.
XZO closed Monday up 3.37% at $23.32, trading as high as $23.66 and within reach of a 52-week high of $23.75, according to StockAnalysis. Exzeo’s market value stands around $2.1 billion.
Wall Street coverage has been building since the IPO. Truist initiated the stock with a buy rating and a $25 price target, while Citizens JMP started with a “market outperform” rating and a $27 target, according to Finviz. Price targets are analysts’ published estimates of where a stock could trade over the next 12 months. Finviz
Exzeo’s last company update came earlier this month, when it reported third-quarter results. Revenue rose 90% to $55.2 million and “managed premium” — insurance premium volume flowing through its platform — climbed to $1.2 billion, the company said. Nasdaq
Investors have also monitored insider signals. Chief Executive Paresh Patel adopted a Rule 10b5-1 plan — a pre-arranged trading program used to reduce perceptions of trading on inside information — to buy up to 100,000 shares or $2 million of stock, an 8-K filing showed. A Form 4 filing disclosed transactions by the company’s general counsel dated Dec. 18.
Peer moves were mixed in early trading. Lemonade fell about 4.5% while Root rose about 1%, and Exzeo parent HCI Group was up about 0.3% in late trade.
Before the opening bell, traders will parse U.S. housing and funding-rate data for clues on rates and risk appetite. The St. Louis Fed’s release calendar shows the S&P CoreLogic Case-Shiller home price index and SOFR (the Secured Overnight Financing Rate) averages among scheduled releases on Tuesday.
For XZO, the near-term question is whether Monday’s push toward recent highs can attract follow-through once holiday-thinned conditions fade. A lack of fresh company-specific catalysts makes the stock more vulnerable to the day’s macro tone.
The next company milestone is its next quarterly report. Zacks lists March 11, 2026 as an estimated earnings date, and investors will be watching for sustained premium growth and any update on margins as the firm scales its insurance-operations platform.
Related articles: NYSE:XZO
